Filing Details
- Accession Number:
- 0000899243-19-027471
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-11-18 10:01:32
- Reporting Period:
- 2019-11-15
- Accepted Time:
- 2019-11-18 10:01:32
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1133416 | Galectin Therapeutics Inc | GALT | Pharmaceutical Preparations (2834) | 043562325 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1522478 | D Kevin Freeman | C/O Galectin Therapeutics, Inc. 4960 Peachtree Industrial Blvd., Suite 240 Norcross GA 30071 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-11-15 | 3,000 | $3.36 | 14,000 | No | 4 | P | Indirect | By a limited liability company controlled by the Reporting Person: Freeman Global Holdings, LLC |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | By a limited liability company controlled by the Reporting Person: Freeman Global Holdings, LLC |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 23,469 | Direct | |
| Common Stock | 16,000 | Indirect | IRA |
Footnotes
- Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
Billionaire Hedge Funds
